[Federal Register Volume 70, Number 101 (Thursday, May 26, 2005)]
[Notices]
[Pages 30420-30421]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-10490]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Meeting of the Uniform Formulary Beneficiary Advisory Panel

AGENCY: Department of Defense, Assistant Secretary of Defense (Health 
Affairs).

ACTION: Notice; meeting of the Uniform Formulary Beneficiary Advisory 
Panel.

-----------------------------------------------------------------------

SUMMARY: This notice announces a meeting of the Uniform Formulary 
Beneficiary Advisory Panel. The panel will review and comment on 
recommendations made to the Director, TRICARE Management Activity, by 
the Pharmacy and Therapeutics Committee regarding the Uniform 
Formulary. The meeting will be open to the public. Seating is limited 
and will be provided only to the first 220 people signing in. All 
persons must sign in legibly. Notice of this meeting is required under 
the Federal Advisory Committee Act.

DATES: Monday, June 27, 2005, from 8 a.m. to 4 p.m.

ADDRESSES: Naval Heritage Center Theater, 701 Pennsylvania Avenue NW., 
Washington, DC 20004.

FOR FURTHER INFORMATION CONTACT: Rich Martel, TRICARE Management 
Activity, Pharmacy Operations, Beneficiary Advisory Panel, Suite 810, 
5111 Leesburg Pike, Falls Church, VA 22041, telephone 703-681-0064 ext. 
3672, fax 703-681-1242, or e-mail at [email protected].

SUPPLEMENTARY INFORMATION: The Uniform Formulary Beneficiary Advisory 
Panel will only review and comment on the development of the uniform 
formulary as reflected in the recommendations of the Pharmacy and 
Therapeutics Committee coming out of that body's meeting in May 2005. 
The DoD P&T information and subject matter concerning drug classes 
reviewed for that meeting are available at http://www.pec.ha.osd.mil. 
The website for the Beneficiary Advisory Panel is at http://www.tricare.osd.mil/pharmacy/bap. Any private citizen is permitted to 
file a written statement with the advisory panel. Statements must be 
submitted electronically to The Uniform Formulary Beneficiary Advisory 
Panel, c/o Mr. Richard Martel, [email protected]. In order to

[[Page 30421]]

be considered by the panel prior to the meeting, statements must be 
submitted electronically no later than June 21, 2005. Any private 
citizen is permitted to speak at the Beneficiary Advisory Panel 
meeting, time permitting. One hour has been reserved for public 
comments, and speaking times will be assigned on a first-come, first-
served basis. The amount of time allocated to a speaker will not exceed 
five minutes. Private citizens wishing to speak at the meeting may sign 
up at the meeting on a first-come, first-served basis.

    Dated: May 20, 2005.
Jeannette Owings-Ballard,
OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 05-10490 Filed 5-25-05; 8:45 am]
BILLING CODE 5001-06-P